CAM
Cormorant Asset Management’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-150,000
| Closed | -$3.67M | – | 69 |
|
|
2019
Q1 | $3.67M | Sell |
150,000
-15,682
| -9% | -$383K | 0.25% | 53 |
|
|
2018
Q4 | $4.3M | Sell |
165,682
-4,318
| -3% | -$112K | 0.35% | 48 |
|
|
2018
Q3 | $5.38M | Sell |
170,000
-21,108
| -11% | -$668K | 0.35% | 44 |
|
|
2018
Q2 | $7.43M | Hold |
191,108
| – | – | 0.55% | 42 |
|
|
2018
Q1 | $5.28M | Sell |
191,108
-8,892
| -4% | -$245K | 0.39% | 36 |
|
|
2017
Q4 | $3.62M | Sell |
200,000
-370,000
| -65% | -$6.7M | 0.38% | 41 |
|
|
2017
Q3 | $9.21M | Hold |
570,000
| – | – | 1.63% | 19 |
|
|
2017
Q2 | $7.89M | Sell |
570,000
-630,000
| -53% | -$8.72M | 1.31% | 24 |
|
|
2017
Q1 | $18M | Sell |
1,200,000
-751,263
| -39% | -$11.3M | 2.61% | 13 |
|
|
2016
Q4 | $25.6M | Buy |
1,951,263
+180,000
| +10% | +$2.36M | 3.45% | 9 |
|
|
2016
Q3 | $30.5M | Hold |
1,771,263
| – | – | 3.37% | 8 |
|
|
2016
Q2 | $32M | Buy |
1,771,263
+21,263
| +1% | +$384K | 4.53% | 3 |
|
|
2016
Q1 | $33.2M | Buy |
1,750,000
+64,281
| +4% | +$1.22M | 5.01% | 2 |
|
|
2015
Q4 | $45M | Hold |
1,685,719
| – | – | 5.38% | 3 |
|
|
2015
Q3 | $41.1M | Buy |
1,685,719
+245,719
| +17% | +$6M | 6.57% | 1 |
|
|
2015
Q2 | $44.9M | Buy |
1,440,000
+170,000
| +13% | +$5.3M | 5.97% | 2 |
|
|
2015
Q1 | $18.5M | Buy |
1,270,000
+570,000
| +81% | +$8.29M | 2.86% | 11 |
|
|
2014
Q4 | $7.04M | Hold |
700,000
| – | – | 1.09% | 27 |
|
|
2014
Q3 | $5.83M | Hold |
700,000
| – | – | 1.2% | 22 |
|
|
2014
Q2 | $8.62M | Buy |
+700,000
| New | +$8.62M | 2.29% | 14 |
|